While a phase III study progresses, Acceleron is searching for different populations of MDS patients where luspatercept might also be effective.
J&J will appeal $1 billion in punitive damages to six people injured by a hip implant. The plaintiffs' lawyer argued two losses in Pinnacle cases should convince J&J to settle.
U.S. stock futures slip and oil prices decline ahead of the U.S. payrolls report for November; Starbucks falls after CEO Howard Schultz announces he will step down in April 2017.
Jim Cramer is watching Johnson & Johnson, which may buy a Swiss drugmaker. Cramer says it's important to see how the deal is structured.